Dr. Vega-Vazquez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
MD Anderson Cancer Center
Houston, TX 77030Phone+1 713-563-1294
Summary
- I received my MD degree from the Universidad Complutense of Madrid (Spain) and my PhD in Cellular Biology by the Universidad de Navarra (Spain). I completed my residency-training program in Anatomic Pathology in the Clinica Universitaria de Navarra, Pamplona (Spain), and repeated an Anatomic Pathology residency in the United States at Baylor College of Medicine (Houston, TX). I worked as a Surgical Pathologist in the Department of Pathology of the Hospital de Orense (Galicia, Spain) from January 1998 to November 1999. I completed a fellowship in Hematopathology at M.D. Anderson Cancer Center (MDACC; Houston) in 2005. I am board certified in Anatomic Pathology, and in the subspecialty of Hematopathology, by the American Board of Pathology. I have been Associate Professor with the award of tenure and Chief of the Lymphoma Section at the Department of Hematopathology at MDACC until August 2013. I moved to the University of Miami (UM)/Sylvester Comprehensive Cancer Center to be the Director of the Division of Hematopathology in September 2013. Since then, I have done diagnostic signout in hematopathology and lead a research laboratory investigating signaling pathways that can be useful for targeted therapy in lymphoma.
My patient care activities center around the diagnosis of specimens obtained from patients being evaluated for leukemia, lymphoma and/or plasma cell myeloma. I interpret bone marrow core biopsy and aspirate specimens; lymph node and tissue biopsies; immunophenotypic analyses, including immunohistochemistry and flow cytometry; and peripheral blood smears. I act as a consultant to the surgical pathology services and to other members of the Division of Hematopathology as well as colleagues from other institutions and clinical groups.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Hematopathology, 2005 - 2006
Baylor College of MedicineResidency, Pathology-Anatomic and Clinical, 2003 - 2005
University of NavarraPh.D., Cell Biology, 1997
Complutense University of MadridClass of 1992
Certifications & Licensure
TX State Medical License 2006 - 2025
FL State Medical License 2013 - 2021- American Board of Pathology Anatomic Pathology
- American Board of Pathology Hematopathology
Awards, Honors, & Recognition
- Janice Davis Singletary Award for Clinical Fellowship in Lymphoma MD Anderson Cancer Center, 2006
- Award for Best Platform Presentation Galician Society of Gastroenterology, 1999
- Scholarship Government of Navarra, Pamplona, Spain, 1996
- Join now to see all
Publications & Presentations
PubMed
- 40 citationsEx-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot studyRonan T. Swords, Diana J. Azzam, Hassan Al-Ali, Ines Lohse, Claude-Henry Volmar
Leukemia Research. 2018-01-01 - 136 citationsABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphomaRajesh R. Singh, Kranthi Kunkalla, Changju Qu, Ellen J. Schlette, Sattva S. Neelapu
Oncogene. 2011-12-08 - 99 citationsExtranodal lymphomas of the head and neckFrancisco Vega, Pei Lin, L. Jeffrey Medeiros
Annals of Diagnostic Pathology. 2005-12-01
Journal Articles
- Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?Campuzano-Zuluaga G, Deutsch Y, Salzberg M, Gomez A, Vargas F, Elias R, Kwon D, Goodman M, Ikpatt OF, Chapman JR, Watts J, Vega F, Swords R, Am J Hematol, 1/1/2016
- Unusual immunophenotypic variant of large B-cell lymphoma associated with HHV-8 and EBV in an HIV positive patientRuiz-Cordero, R, Lewis J, Blieden C, Campuzano-Zuluaga G, Hernandez J, Lossos IS, Ikpatt F, Chapman JR, Vega F, Hum Path: Case Reports, 1/1/2015
- Synaptophysin is frequently expressed in megakaryocytes: a novel immunohistochemical finding of unknown significanceRuiz-Cordero R, Chapman J, Vega F, Rev LatinoAmer Patol Clin, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Role of SMO in the activation of PI3k/AKT signaling in DLBCL.Haghefi A, Agarwal NK Kunkalla K, Kim CH, Tjendra Y, Landgraf R, Vega F, USCAP, San Antonio, TX, 1/1/2017
- Mutational Frequency in Hispanic and Non-Hispanic Patients with Acute Myeloid Leukemia (AML): Updated Analysis of 227 Patients.Bradley TJ, Monge J, Talati C, Algaze SD, Vaupel CA, Chapman JR, Vega F, Hall J, Lancet JE, Padron E, Swords R, Watts JM, ASH, Atlanta, GA, 1/1/2017
- Smoothened Stabilizes and Protects TRAF6 from Proteosomal Degradation: A Novel Non-Canonical Role of Smoothened with Implications in Lymphoma Biology.Qu C, Vaghefi A, Kunkalla K, Chapman JR, Liu Y, Blonska M, Alderuccio JP, Bernal-Mizrachi L, Lossos IS, Landgraf R, Vega F, ASH, Atlanta, GA, 1/1/2017
- Join now to see all
Lectures
- Genetic Analysis of Plasmablastic Lymphomas in HIV (+) Patients Reveals Novel Driver Regulators of the Noncanonical NF-Κb Pathway2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL - 1/1/2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
